About
BactoByte aims to empower caregivers with one-hour bacterial diagnostics and antibiotic screening capability to improve outcomes, reduce mis-diagnostics, and lower health care costs. Based on our proprietary basic method, BactoByte's assay delivers precise and cost-effective identification and direct antibiotics susceptibility testing with 80-90% improvement of standard turnaround time. Time reduction, sensitivity, and specificity results in decreased mortality rates, fewer hospital days, and avoidance of associated costs of $1K-50K per patient. BactoByte has technology validation and partnerships with leading medical centers.
Technologies
Gmail
Google Apps
Amazon AWS
Nginx
Ubuntu
Mobile Friendly
Laravel
Android
Keywords
medical device
healthcare
rapid microbiology
laboratory science
in vitro diagnostics
biotechnology
medical equipment manufacturing
medical diagnostics
rapid pathogen detection
rapid infectious disease testing
pathogen screening
fluorescent staining technology
intracellular testing
metabolic activation
single cell analysis
microbiology automation
semi-automated system
disruptive innovation
antibiotic susceptibility testing
antibiotic resistance testing
research and development in the physical
engineering
and life sciences
clinical microbiology
biological system technology
reporting software system
b2b
metabolic activity monitoring
growth promotion
disruptive healthcare technology
Company Information
-
Employees 5
-
Founded 2017
Location
Kerem Junction, Jerusalem, Jerusalem District, Israel, 90000
